Deltagen (Deltagen) Short-Term Debt : $0.00 Mil (As of Jun. 2007)

View and export this data going back to 2000. Start your Free Trial

What is Deltagen Short-Term Debt?

Deltagen's Short-Term Debt for the quarter that ended in Jun. 2007 was $0.00 Mil.

Deltagen's annual Short-Term Debt declined from Dec. 2002 ($12.58 Mil) to Dec. 2005 ($0.00 Mil) but then stayed the same from Dec. 2005 ($0.00 Mil) to Dec. 2006 ($0.00 Mil).

Deltagen Short-Term Debt Historical Data

The historical data trend for Deltagen's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deltagen Short-Term Debt Chart

Deltagen Annual Data

Trend

Dec99

Dec00

Dec01

Dec02

Dec05

Dec06

Short-Term Debt

Get a 7-Day Free Trial

1.60

2.38

12.58

Deltagen Quarterly Data
	Dec99	Mar00	Jun00	Sep00	Dec00	Mar01	Jun01	Sep01	Dec01	Mar02	Jun02	Sep02	Dec02	Mar03	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07
Short-Term Debt	Get a 7-Day Free Trial															-	-	-	-	-

Deltagen Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Deltagen Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Deltagen's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Deltagen (Deltagen) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Deltagen Inc (OTCPK:DGEN) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

1900 S. Norfolk Street, Suite 105, San Mateo, CA, USA, 94403

Website

http://www.deltagen.com

Deltagen Inc is a provider of drug discovery tools and services to the biopharmaceutical industry.

Deltagen (Deltagen) Headlines

No Headlines